tetano
Editor, Senior Moderator
Sci Rep. 2016 Jan 12;6:19095. doi: 10.1038/srep19095.
[h=1]Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.[/h] Liu Z[SUP]1[/SUP], Zhao J[SUP]1[/SUP], Li W[SUP]1[/SUP], Shen L[SUP]1[/SUP], Huang S[SUP]2[/SUP], Tang J[SUP]2[/SUP], Duan J[SUP]2[/SUP], Fang F[SUP]2[/SUP], Huang Y[SUP]1[/SUP], Chang H[SUP]2[/SUP], Chen Z[SUP]2[/SUP], Zhang R[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Influenza A virus is a great threat for human health, while various subtypes of the virus made it difficult to develop drugs. With the development of state-of-art computational chemistry, computational molecular docking could serve as a virtual screen of potential leading compound. In this study, we performed molecular docking for influenza A H1N1 (A/PR/8/34) with small molecules such as quercetin and chlorogenic acid, which were derived from traditional Chinese medicine. The results showed that these small molecules have strong binding abilities with neuraminidase from H1N1 (A/PR/8/34). Further details showed that the structural features of the molecules might be helpful for further drug design and development. The experiments in vitro, in vivo have validated the anti-influenza effect of quercetin and chlorogenic acid, which indicating comparable protection effects as zanamivir. Taken together, it was proposed that chlorogenic acid and quercetin could be employed as the effective lead compounds for anti-influenza A H1N1.
PMID: 26754609 [PubMed - in process] Free full text
[h=1]Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.[/h] Liu Z[SUP]1[/SUP], Zhao J[SUP]1[/SUP], Li W[SUP]1[/SUP], Shen L[SUP]1[/SUP], Huang S[SUP]2[/SUP], Tang J[SUP]2[/SUP], Duan J[SUP]2[/SUP], Fang F[SUP]2[/SUP], Huang Y[SUP]1[/SUP], Chang H[SUP]2[/SUP], Chen Z[SUP]2[/SUP], Zhang R[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The Influenza A virus is a great threat for human health, while various subtypes of the virus made it difficult to develop drugs. With the development of state-of-art computational chemistry, computational molecular docking could serve as a virtual screen of potential leading compound. In this study, we performed molecular docking for influenza A H1N1 (A/PR/8/34) with small molecules such as quercetin and chlorogenic acid, which were derived from traditional Chinese medicine. The results showed that these small molecules have strong binding abilities with neuraminidase from H1N1 (A/PR/8/34). Further details showed that the structural features of the molecules might be helpful for further drug design and development. The experiments in vitro, in vivo have validated the anti-influenza effect of quercetin and chlorogenic acid, which indicating comparable protection effects as zanamivir. Taken together, it was proposed that chlorogenic acid and quercetin could be employed as the effective lead compounds for anti-influenza A H1N1.
PMID: 26754609 [PubMed - in process] Free full text